LEXARIA BIOSCIENCE CORP. Proceeds from Issuance of Private Placement
LEXARIA BIOSCIENCE CORP. (LEXX) reported Proceeds from Issuance of Private Placement of $1.29 million for the 0-month period ending 2023-10-03, per its 10-K filed 2023-11-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2023-11-20
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of private placement for the quarter ending 2016-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of private placement for the quarter ending 2015-11-30 was $36.00K.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of private placement for the quarter ending 2012-01-31 was $200.00K, a 67.74% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of private placement for the quarter ending 2011-10-31 was -$33.09K.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of private placement for fiscal 2011 was $36.91K, a 79.88% decline from fiscal 2010.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of private placement for fiscal 2010 was $183.40K.
| Period end | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 2 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|---|---|
| 2023-10-03 | $1.29M 10-K · filed 2023-11-20 | ||||||
| 2018-10-31 | $1.52M 10-Q · filed 2019-07-08 | ||||||
| 2017-10-31 | $93.50K 10-K · filed 2018-11-14 | ||||||
| 2017-05-31 | $1.64M 10-Q · filed 2017-07-14 | ||||||
| 2017-04-03 | $1.72M 10-K · filed 2018-11-14 | ||||||
| 2017-02-28 | $93.50K 10-Q · filed 2017-04-14 | ||||||
| 2016-11-30 | $0.00 10-Q · filed 2017-01-13 | ||||||
| 2016-05-31 | $147.48K 10-Q · filed 2017-07-14 | ||||||
| 2016-02-29 | $86.98K 10-Q · filed 2017-04-14 | ||||||
| 2015-11-30 | $36.00K 10-Q · filed 2017-01-13 | ||||||
| 2012-01-31 | $200.00K 10-Q · filed 2012-03-13 | $166.91K derived: sum of 2 quarters · filed 2012-03-13 | |||||
| 2011-10-31 | -$33.09K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $36.91K 10-K · filed 2012-01-30 | |||||
| 2011-07-31 | $70.00K 10-Q · filed 2011-09-14 | ||||||
| 2011-01-31 | $620.00K 10-Q · filed 2012-03-13 | $620.00K derived: sum of 2 quarters · filed 2012-03-13 | |||||
| 2010-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $183.40K 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $183.40K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |